Joseph Baroldi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ionis Pharmaceuticals (NASDAQ:IONS) Reaches New 1-Year Low at $36 44

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) shares reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as $36.44 and last traded at $36.44, with a volume of 220851 shares traded. The stock had previously closed at $37.64. Analyst Ratings Changes Several equities analysts have recently weighed […]

United statesPiper sandlerJoseph baroldiWilliam blairHedge funds weigh in on ionis pharmaceuticalsNews ratings for ionis pharmaceuticals dailyIonis pharmaceuticalsIonis pharmaceuticals stock downMather groupSunbelt securities incWells fargo companySecurities exchange commissionIonis pharmaceuticals company profilePingora partnersIonis pharmaceuticals incGet free report

First Turn Management LLC Invests $18 04 Million in Ionis Pharmaceuticals, Inc (NASDAQ:IONS)

First Turn Management LLC Invests $18 04 Million in Ionis Pharmaceuticals, Inc (NASDAQ:IONS)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerJoseph baroldiWilliam blairQuarter for ionis pharmaceuticalsNeedham companySecurities exchange commissionIonis pharmaceuticalsIonis pharmaceuticals incLisanti capital growthFirst turn managementIonis pharmaceuticals company profileNews ratings for ionis pharmaceuticals dailyWells fargo companyRoyal bankIonis pharmaceuticals price performance

Ionis Pharmaceuticals, Inc (NASDAQ:IONS) Receives $56 08 Average Price Target from Analysts

Ionis Pharmaceuticals, Inc (NASDAQ:IONS) Receives $56 08 Average Price Target from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesJoseph baroldiWilliam blairNews ratings for ionis pharmaceuticals dailyInsider transactions at ionis pharmaceuticalsHedge funds weigh in on ionis pharmaceuticalsJpmorgan chase coIonis pharmaceuticals incWolfe researchBoard of administration florida retirement systemIonis pharmaceuticals price performanceAnalyst recommendations for ionis pharmaceuticalsBleakley financial groupBlair william coSecurities exchange commissionIonis pharmaceuticals

Ionis Pharmaceuticals, Inc (NASDAQ:IONS) Receives Average Rating of Moderate Buy from Brokerages

Ionis Pharmaceuticals, Inc (NASDAQ:IONS) Receives Average Rating of Moderate Buy from Brokerages
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United statesJoseph baroldiHedge funds weigh in on ionis pharmaceuticalsSecurities exchange commissionIonis pharmaceuticalsNeedham companyWells fargo companyIonis pharmaceuticals incNews ratings for ionis pharmaceuticals dailyAnalyst recommendations for ionis pharmaceuticalsIonis pharmaceuticals stock downMather groupRoyal bankPingora partnersPeoples bankGet free report

Ionis Pharmaceuticals (NASDAQ:IONS) Releases Quarterly Earnings Results, Beats Expectations By $0 12 EPS

Ionis Pharmaceuticals (NASDAQ:IONS) Releases Quarterly Earnings Results, Beats Expectations By $0 12 EPS
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United statesJoseph baroldiWolfe researchIonis pharmaceuticals price performanceWells fargo companyNeedham companyEarnings history for ionis pharmaceuticalsIonis pharmaceuticalsNews ratings for ionis pharmaceuticals dailyJpmorgan chase coIonis pharmaceuticals incInsider transactions at ionis pharmaceuticalsGet free reportDirector joseph kleinWells fargoIonis pharmaceuticals daily